New Delhi: India is witnessing a surge in mucormycosis or black fungus cases and states are facing a shortage of Amphotericin B injections, which is an antifungal drug to treat this rare disease. Congress has blamed the Centre for drug shortage due to insufficient supply.
While the Congress party blames the Central government for not making arrangements on time, it also suggested that strict action needs to be taken against those who are black marketeering or hoarding these life-saving drugs including Remdesevir and Amphotericin B at this time of crisis.
Read:|Developing antibodies depends on immune system: Expert
In a conversation with ETV Bharat, Congress spokesperson Supriya Shrinate said, "It is such a tragedy that every time there is a need for medicine, oxygen or vaccines, shortages happen and that too in a country which is called as the pharma laboratory of the world. Now reports are coming in that antifungal drugs for black fungus is running short of the supply, while there is black marketing or hoarding is happening. What exactly is the Central government doing?"
She further added, "You have to crack down on hoarders. People who are profiteering from the plight of our population must be punished and the Centre needs to show a resolve to crack down on these people."
Recently, trader's union, Confederation of All India Traders (CAIT) had sent a letter to Union Health Minister Dr Harshvardhan, anticipating black marketing and unethical sale of Liposomal salt injections, demanding that supply of such injections should be taken under control of the Central government who in turn ensure delivery of these injections directly to hospitals only through state governments.
Congress leader and former Union Minister Rajeev Shukla also spoke over the matter, suggesting, "Earlier there was a crisis of Remdesivir injection and now the same is happening with the antifungal injection for black fungus. The government should immediately start preparing for that. If it needs to get imported then start doing it. Immediately ensure the availability of this injection in our domestic drug companies."